CEDAR

CEDAR catalogs cancer-associated epitopes and associated receptor information to enable analysis of adaptive T cell and B cell responses and molecular characterization of cancer antigens.


Key Features:

  • Cancer epitope cataloging: Systematic compilation of epitopes specifically in the context of cancer.
  • Adaptive immune scope: Records epitopes recognized by adaptive T cell and B cell immune responses.
  • Receptor information: Includes associated receptor data linked to epitopes.
  • Molecular characterization: Stores detailed molecular characteristics of cancer epitopes.
  • Metadata annotation: Captures relevant metadata for epitopes and associated entries.
  • Literature curation: Entries are compiled from the scientific literature.
  • IEDB complementarity: Focuses on cancer-related epitopes complementary to the Immune Epitope Database (IEDB) scope.

Scientific Applications:

  • Immunological characterization: Analysis of naturally occurring immune responses to tumor-derived antigens.
  • Cancer immunopathology studies: Investigation of immune mechanisms and pathology in cancer.
  • Therapeutic development: Informing design and evaluation of cancer immunotherapies and therapeutic interventions.
  • Prophylactic planning: Supporting planning of prophylactic measures related to cancer antigens.
  • Comparative epitope analysis: Enabling comparisons between cancer epitope data and IEDB datasets.

Methodology:

Curated compilation from the scientific literature with annotation of epitope entries including associated receptor information, molecular characteristics, and relevant metadata.

Topics

Details

License:
Other
Cost:
Free of charge
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Added:
12/23/2022
Last Updated:
11/24/2024

Operations

Publications

Koşaloğlu-Yalçın Z, Blazeska N, Vita R, Carter H, Nielsen M, Schoenberger S, Sette A, Peters B. The Cancer Epitope Database and Analysis Resource (CEDAR). Nucleic Acids Research. 2022;51(D1):D845-D852. doi:10.1093/nar/gkac902. PMID:36250634. PMCID:PMC9825495.

PMID: 36250634
PMCID: PMC9825495
Funding: - National Institutes of Health: 75N93019C00001, U24CA248138